This inventor holds 21 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 11 EPO patents, primarily in Nucleic Acid Synthesis. Top assignees: Nitto-Denko Corporation, Nagoya University, Nitto Electric Industrial Co., Ltd.. Active years: 1987-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Osaka, JP (1987 - 2014)
- Ibaraki, JP (2002 - 2019)
Company Filing History:
18 out of 3,951 
2 out of 371 
2 out of 172 
Years Active: 1987-2019
Areas of Expertise:
Title: Kenjiro Mori: Innovator in Nucleic Acid Synthesis
Introduction
Kenjiro Mori, based in Ibaraki, Japan, is a prolific inventor with a remarkable portfolio of 21 patents to his name. His work primarily focuses on advanced techniques in nucleic acid synthesis, reflecting his deep commitment to innovation in the field of biotechnology.
Latest Patents
Among Kenjiro Mori's latest contributions to the scientific community are significant patents aimed at enhancing nucleic acid synthesis. One of his notable inventions is a linker and support for solid phase synthesis of nucleic acid, which provides a streamlined method by incorporating compounds represented by specific formulas, improving the efficiency of nucleic acid production. Another crucial patent he developed is a method of cutting out RNA oligonucleotides, which effectively minimizes byproduct production while maximizing yield. This method utilizes a universal support in conjunction with an aqueous solution containing alkylamine and a monovalent inorganic salt, showcasing Kenjiro's innovative approach to complex biochemical processes.
Career Highlights
Throughout his career, Kenjiro Mori has made significant strides in the biotech industry, working with reputable companies such as Nitto Denko Corporation and Nitto Electric Industrial Co., Ltd. His extensive experience has equipped him with a robust understanding of the industry, allowing him to contribute valuable inventions that push the boundaries of current technology in nucleic acid synthesis.
Collaborations
Kenjiro often collaborates with fellow innovators in his field, notably working alongside Tatsuya Konishi and Eri Maeta. These collaborations have fueled creativity and innovation, leading to the development of advanced methodologies and furthering the study and application of nucleic acids.
Conclusion
Kenjiro Mori's dedication to innovation in nucleic acid synthesis is evident through his impressive patent portfolio and collaborative efforts. His work not only showcases his technical expertise but also contributes significantly to advancements in biotechnology, paving the way for future discoveries and innovations in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile